(OTIS) Otis Worldwide - Ratings and Ratios
Elevators, Escalators, Maintenance, Modernization
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.88% |
| Yield on Cost 5y | 2.63% |
| Yield CAGR 5y | 25.95% |
| Payout Consistency | 100.0% |
| Payout Ratio | 42.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 17.7% |
| Value at Risk 5%th | 30.0% |
| Relative Tail Risk | 2.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -13.58 |
| CAGR/Max DD | 0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.382 |
| Beta | 0.401 |
| Beta Downside | 0.465 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.90% |
| Mean DD | 6.45% |
| Median DD | 5.58% |
Description: OTIS Otis Worldwide December 03, 2025
Otis Worldwide Corp (NYSE:OTIS) manufactures, installs, and services elevators, escalators, and moving walkways across the United States, China, and other global markets, operating through two distinct segments: New Equipment (design, build, and sale of passenger/freight elevators and escalators) and Service (maintenance, repair, and modernization of existing assets). The New Equipment segment primarily serves real-estate developers and contractors, while the Service segment generates recurring revenue from a worldwide installed base.
Key metrics that shape Otis’s outlook include a FY2023 revenue of roughly $13.5 billion, with service contracts contributing about 70 % of total sales, providing a defensive cash-flow buffer against construction-cycle volatility. The company’s order backlog has risen to over $15 billion, reflecting strong demand in emerging-market infrastructure projects and urbanization trends in China. Additionally, rising interest rates have modestly suppressed new-equipment spending, making the high-margin service segment a critical driver of earnings stability.
For a deeper, data-driven dive into Otis’s valuation dynamics, consider exploring the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (1.35b TTM) > 0 and > 6% of Revenue (6% = 858.6m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -0.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.17% (prev -11.28%; Δ 8.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 1.47b > Net Income 1.35b (YES >=105%, WARN >=100%) |
| Net Debt (7.65b) to EBITDA (2.25b) ratio: 3.40 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (392.8m) change vs 12m ago -2.46% (target <= -2.0% for YES) |
| Gross Margin 30.40% (prev 30.21%; Δ 0.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 136.1% (prev 138.4%; Δ -2.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.51 (EBITDA TTM 2.25b / Interest Expense TTM 180.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.83
| (A) -0.04 = (Total Current Assets 6.61b - Total Current Liabilities 7.07b) / Total Assets 10.77b |
| (B) -0.04 = Retained Earnings (Balance) -453.0m / Total Assets 10.77b |
| (C) 0.20 = EBIT TTM 2.07b / Avg Total Assets 10.52b |
| (D) -0.08 = Book Value of Equity -1.22b / Total Liabilities 16.06b |
| Total Rating: 0.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.24
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.15% |
| 3. FCF Margin 9.25% |
| 4. Debt/Equity -1.57 |
| 5. Debt/Ebitda 3.40 |
| 6. ROIC - WACC (= 46.72)% |
| 7. RoE -25.95% |
| 8. Rev. Trend 38.46% |
| 9. EPS Trend 84.02% |
What is the price of OTIS shares?
Over the past week, the price has changed by +0.81%, over one month by -0.23%, over three months by -3.21% and over the past year by -3.29%.
Is OTIS a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 9
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the OTIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 104 | 18.2% |
| Analysts Target Price | 104 | 18.2% |
| ValueRay Target Price | 89.7 | 2% |
OTIS Fundamental Data Overview December 28, 2025
P/E Trailing = 25.8466
P/E Forward = 19.7239
P/S = 2.4031
P/B = 13.1987
P/EG = 2.1722
Beta = 1.007
Revenue TTM = 14.31b USD
EBIT TTM = 2.07b USD
EBITDA TTM = 2.25b USD
Long Term Debt = 7.59b USD (from longTermDebt, last quarter)
Short Term Debt = 492.0m USD (from shortTermDebt, last quarter)
Debt = 8.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.65b USD (from netDebt column, last quarter)
Enterprise Value = 42.04b USD (34.39b + Debt 8.49b - CCE 840.0m)
Interest Coverage Ratio = 11.51 (Ebit TTM 2.07b / Interest Expense TTM 180.0m)
FCF Yield = 3.15% (FCF TTM 1.32b / Enterprise Value 42.04b)
FCF Margin = 9.25% (FCF TTM 1.32b / Revenue TTM 14.31b)
Net Margin = 9.41% (Net Income TTM 1.35b / Revenue TTM 14.31b)
Gross Margin = 30.40% ((Revenue TTM 14.31b - Cost of Revenue TTM 9.96b) / Revenue TTM)
Gross Margin QoQ = 30.70% (prev 30.43%)
Tobins Q-Ratio = 3.90 (Enterprise Value 42.04b / Total Assets 10.77b)
Interest Expense / Debt = 0.72% (Interest Expense 61.0m / Debt 8.49b)
Taxrate = 24.76% (129.0m / 521.0m)
NOPAT = 1.56b (EBIT 2.07b * (1 - 24.76%))
Current Ratio = 0.94 (Total Current Assets 6.61b / Total Current Liabilities 7.07b)
Debt / Equity = -1.57 (negative equity) (Debt 8.49b / totalStockholderEquity, last quarter -5.42b)
Debt / EBITDA = 3.40 (Net Debt 7.65b / EBITDA 2.25b)
Debt / FCF = 5.78 (Net Debt 7.65b / FCF TTM 1.32b)
Total Stockholder Equity = -5.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.51% (Net Income 1.35b / Total Assets 10.77b)
RoE = -25.95% (negative equity) (Net Income TTM 1.35b / Total Stockholder Equity -5.19b)
RoCE = 86.26% (EBIT 2.07b / Capital Employed (Equity -5.19b + L.T.Debt 7.59b))
RoIC = 52.83% (NOPAT 1.56b / Invested Capital 2.95b)
WACC = 6.11% (E(34.39b)/V(42.88b) * Re(7.49%) + D(8.49b)/V(42.88b) * Rd(0.72%) * (1-Tc(0.25)))
Discount Rate = 7.49% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.27%
[DCF Debug] Terminal Value 78.17% ; FCFE base≈1.33b ; Y1≈1.32b ; Y5≈1.38b
Fair Price DCF = 62.67 (DCF Value 24.42b / Shares Outstanding 389.7m; 5y FCF grow -1.51% → 3.0% )
EPS Correlation: 84.02 | EPS CAGR: 10.58% | SUE: 1.19 | # QB: 2
Revenue Correlation: 38.46 | Revenue CAGR: 0.89% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.01 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=4.48 | Chg30d=+0.019 | Revisions Net=-1 | Growth EPS=+10.2% | Growth Revenue=+4.9%
Additional Sources for OTIS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle